111 Inc Revenue Growth Rates (YI), Current and Historic Growth - CSIMarket
CSIMarket
 


111 Inc   (NASDAQ: YI)
 

YI's Revenue Growth by Quarter and Year

111 Inc 's Revenue results by quarter and year




YI Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 1,795.49
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 1,795.49

YIs Annual Revenue
111 Inc 's Revenue in the fiscal year 2025 $ 1,795.49 millions
111 Inc 's Revenue in the fiscal year 2024 $ 1,972.96 millions
111 Inc 's Revenue in the fiscal year 2023 $ 2,105.40 millions
111 Inc 's Revenue in the fiscal year 2022 $ 1,959.74 millions
111 Inc 's Revenue in the fiscal year 2021 $ 1,949.90 millions




YI Revenue fourth quarter 2025 Y/Y Growth Comment
111 Inc reported decrease in Revenue in the fourth quarter 2025 by -9% to $ 1,795.49 millions, from the same quarter in 2024.
The decrease in the fourth quarter 2025 111 Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 14.19%.

Looking into fourth quarter 2025 results within Pharmacy Services & Retail Drugstore industry 5 other companies have achieved higher Revenue growth. While 111 Inc ' s Revenue decline of -9% ranks overall at the positon no. 2174 in the fourth quarter 2025.




YI Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December -9 % -6.29 % 7.43 % 0.5 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   -9 % -6.29 % 7.43 % -

Financial Statements
111 Inc 's fourth quarter 2025 Revenue $ 1,795.49 millions YI's Income Statement
111 Inc 's fourth quarter 2024 Revenue $ 1,972.96 millions Quarterly YI's Income Statement


YI Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   -9 % -6.29 % 7.43 % -




Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #100
Overall #2174

Revenue Y/Y Growth Statistics
High Average Low
55.1 % 14.19 % -6.29 %
(Dec 31 2021)   (Dec 31 2024)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #100
Overall #2174
Revenue Y/Y Growth Statistics
High Average Low
55.1 % 14.19 % -6.29 %
(Dec 31 2021)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

111 Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


YI's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #
Retail Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #
Retail Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


YI's IV. Quarter Q/Q Revenue Comment


111 Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 1,795.49 $ 1,972.96 $ 2,105.40 $ 1,959.74 $ 1,949.90
Y / Y Revenue Growth (TTM) -9 % -6.29 % 7.43 % 0.5 % 55.1 %
Year on Year Revenue Growth Overall Ranking # 403 # 2156 # 0 # 0 # 228
Seqeuential Revenue Change (TTM) -9 % -6.29 % 7.43 % 0.5 % 55.1 %
Seq. Revenue Growth (TTM) Overall Ranking # 403 # 2201 # 0 # 0 # 229


Cumulative Revenue growth Comment
111 Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -9% year on year, at Dec 31 2025 compare to the -6.29% decrease at Dec 31 2024. If the 111 Inc 's fiscal year would end at Dec 31 2025, annual Revenue would be $1,795 millions.

Among companies within the Retail sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 403, from total ranking in previous quarter at 2156.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 0
Retail Sector # 6
Overall # 403

Revenue TTM Y/Y Growth Statistics
High Average Low
55.1 %
9.55 %
-9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 6
S&P 500 # 403
Cumulative Revenue growth Comment
111 Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -9% year on year, at Dec 31 2025 compare to the -6.29% decrease at Dec 31 2024. If the 111 Inc 's fiscal year would end at Dec 31 2025, annual Revenue would be $1,795 millions.

Among companies within the Retail sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 403, from total ranking in previous quarter at 2156.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 0
Retail Sector # 6
Overall # 403

Revenue TTM Y/Y Growth Statistics
High Average Low
55.1 %
9.55 %
-9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 6
S&P 500 # 403




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
YI's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Dec 31 2025 within Retail SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Pool Corporation-0.53%$ -0.534 millions
Sonic Automotive Inc -0.67%$ -0.670 millions
Suburban Propane Partners Lp-0.79%$ -0.788 millions
Pc Connection Inc -0.87%$ -0.868 millions
Insight Enterprises Inc -1.22%$ -1.216 millions
Autozi Internet Technology global Ltd -1.69%$ -1.689 millions
Healthy Choice Wellness Corp -1.69%$ -1.690 millions
Camping World Holdings Inc -2.57%$ -2.566 millions
Live Ventures Inc-2.70%$ -2.702 millions
Lulu s Fashion Lounge Holdings Inc -3.37%$ -3.365 millions
Autonation Inc -3.94%$ -3.937 millions
Birks Group Inc -4.03%$ -4.031 millions
Global Ai Inc -4.38%$ -4.378 millions
Monro Inc -4.41%$ -4.406 millions
Alliance Entertainment Holding Corporation-6.34%$ -6.340 millions
Cosan S a -8.04%$ -8.037 millions
Qvc inc -8.95%$ -8.947 millions
111 Inc -9.00%$ -8.995 millions
Qvc Group Inc -9.10%$ -9.103 millions
1 800 Flowers Com Inc-9.44%$ -9.441 millions
Arko Corp -9.93%$ -9.934 millions
Rush Enterprises Inc -11.83%$ -11.828 millions
Lightinthebox Holding Co Ltd -12.03%$ -12.030 millions
Builders Firstsource Inc -12.12%$ -12.121 millions
Giftify Inc -12.24%$ -12.244 millions
The Honest Company Inc -12.63%$ -12.633 millions
Grove Collaborative Holdings Inc -16.75%$ -16.752 millions
Nu Skin Enterprises Inc -16.89%$ -16.885 millions
Greenlane Holdings Inc -20.27%$ -20.266 millions
Yunji Inc -20.77%$ -20.771 millions


About 111 Inc Revenue Growth Rates (YI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: 111 Inc (CIK 1738906).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-052002
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: 111 Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.